Nand Kumar, MD

Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Psychiatry, Institute of Human Behaviour and Allied Sciences (IHBAS), New Delhi, India

  • 3Articles
  • 16.5KReads1
  • 2018–2026Active
  • 9Collaborators
  • 5Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Nand Kumar, MD, is affiliated with the Department of Psychiatry at the All India Institute of Medical Sciences (AIIMS) and the Institute of Human Behaviour and Allied Sciences (IHBAS) in New Delhi, India. Kumar has published research on psychiatric conditions including schizophrenia and schizoaffective disorders, suicide, and treatment-resistant obsessive-compulsive disorder. The work includes studies on experimental intermittent theta burst stimulation, suicidal vilazodone overdose presenting as serotonin syndrome, and repetitive transcranial magnetic stimulation. Kumar's contributions span from 2018 to 2026 in Psychiatrist.com.

Publications

JCP
Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia
Original Research

Effects of Experimental Intermittent Theta Burst Stimulation on Negative Symptoms of Schizophrenia

May 11, 2026

Findings suggest limited efficacy of experimental intermittent theta burst stimulation over the left DLPFC for negative symptoms.
, , , et al
PCC
Case Report

Suicidal Vilazodone Overdose and Serotonin Syndrome

April 29, 2021

Vilazodone is a novel dual-acting selective serotonin reuptake inhibitor approved for treatment of adult depressive disorders. Here, read about a case of serotonin syndrome in a young woman with...
,
PCC
Letter to the Editor

rTMS for Treatment-Resistant OCD in a Deaf and Mute Woman

July 5, 2018

Many patients with OCD do not respond to traditional treatment. Low-frequency repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area appears to be a promising treatment strategy. Here,...
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe